Evolus, Inc. Common Stock

EOLS

$6.70

Name : Evolus, Inc. Common Stock

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $441,226,816.00

EPSttm : -0.66

Evolus, Inc. Common Stock

$6.70

0.30%

$0.02

EOLS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.12

Margin Of Safety %

Put/Call OI Ratio

0.34

EPS Next Q Diff

0.09

EPS Last/This Y

0.71

EPS This/Next Y

0.36

Price

6.7

Target Price

14.67

Analyst Recom

1.29

Performance Q

26.89

Upside

-450.0%

Beta

1.32

Ticker: EOLS

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	EOLS	6.32	0.30	0.43	14424
2026-05-12	EOLS	6.51	0.30	0.00	14427
2026-05-13	EOLS	6.72	0.30	0.00	14437
2026-05-14	EOLS	6.59	0.29	0.00	14792
2026-05-15	EOLS	6.49	0.29	0.00	14799
2026-05-18	EOLS	6.58	0.34	0.00	12760
2026-05-19	EOLS	6.43	0.34	0.00	12723
2026-05-20	EOLS	6.58	0.34	0.00	12746
2026-05-21	EOLS	6.44	0.33	0.00	12781
2026-05-22	EOLS	6.08	0.33	0.44	12794
2026-05-26	EOLS	6.26	0.33	0.00	12789
2026-05-27	EOLS	6.19	0.34	0.00	12675
2026-05-28	EOLS	6.57	0.34	0.19	12610
2026-05-29	EOLS	6.57	0.34	0.02	12660
2026-06-02	EOLS	6.18	0.34	0.31	12757
2026-06-03	EOLS	6.03	0.34	0.00	12756
2026-06-04	EOLS	6.59	0.34	0.00	12742
2026-06-05	EOLS	6.74	0.34	0.00	12795
2026-06-08	EOLS	6.68	0.34	0.00	12795
2026-06-09	EOLS	6.69	0.34	0.04	12773
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	EOLS	6.32	80.5	12.0	-0.12
2026-05-12	EOLS	6.51	76.6	10.4	-0.12
2026-05-13	EOLS	6.72	76.6	10.4	-0.12
2026-05-14	EOLS	6.59	76.6	10.9	-0.12
2026-05-15	EOLS	6.49	76.6	10.9	-0.12
2026-05-18	EOLS	6.57	76.6	10.6	-0.12
2026-05-19	EOLS	6.43	76.6	10.9	-0.12
2026-05-20	EOLS	6.59	76.6	10.5	-0.12
2026-05-21	EOLS	6.44	76.6	11.0	-0.12
2026-05-22	EOLS	6.08	83.4	11.3	-0.09
2026-05-26	EOLS	6.26	83.4	10.5	-0.09
2026-05-27	EOLS	6.18	83.4	10.9	-0.09
2026-05-28	EOLS	6.57	83.4	10.1	-0.09
2026-05-29	EOLS	6.57	83.4	10.8	-0.09
2026-06-01	EOLS	6.53	83.4	10.8	-0.09
2026-06-02	EOLS	6.18	83.4	11.3	-0.09
2026-06-03	EOLS	6.03	83.4	11.0	-0.09
2026-06-04	EOLS	6.59	83.4	9.9	-0.09
2026-06-05	EOLS	6.68	83.4	10.6	-0.09
2026-06-08	EOLS	6.68	83.4	10.8	-0.09
2026-06-09	EOLS	6.70	83.4	10.7	-0.09
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	EOLS	-1.00	-8.18	13.66
2026-05-12	EOLS	-1.00	-8.18	13.75
2026-05-13	EOLS	-1.00	-8.18	13.75
2026-05-14	EOLS	-1.00	-8.18	13.75
2026-05-15	EOLS	-1.00	-8.18	13.75
2026-05-18	EOLS	-1.00	-7.38	13.75
2026-05-19	EOLS	-1.00	-7.38	13.75
2026-05-20	EOLS	-1.00	-7.38	13.75
2026-05-21	EOLS	-1.00	-7.38	13.75
2026-05-22	EOLS	-1.00	-7.38	13.75
2026-05-26	EOLS	-1.00	-6.81	11.99
2026-05-27	EOLS	-1.68	-6.81	11.99
2026-05-28	EOLS	-1.68	-6.81	11.12
2026-05-29	EOLS	-1.68	-6.81	11.12
2026-06-02	EOLS	-1.68	-7.47	11.12
2026-06-03	EOLS	-1.68	-7.47	11.12
2026-06-04	EOLS	-1.68	-7.47	11.12
2026-06-05	EOLS	-1.68	-7.47	11.12
2026-06-08	EOLS	-1.68	-7.47	11.12
2026-06-09	EOLS	-1.68	-7.47	11.12
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

-0.07

Insider Transactions

-1.68

Institutional Transactions

-7.47

Beta

1.32

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

62.4

Max Drawdown 5-Year %

-77.5

Target Price

14.67

P/E

Forward P/E

25.12

PEG

P/S

1.46

P/B

P/Free Cash Flow

EPS

-0.67

Average EPS Est. Cur. Y

-0.09

EPS Next Y. (Est.)

0.27

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14.39

Relative Volume

0.88

Return on Equity vs Sector %

123.4

Return on Equity vs Industry %

142.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

10.7

◆ EOLS Healthcare

$6.70

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

8/20

Pullback

10/25

Volume

7/15

Valuation

15/20

TP/AR

2/10

Options

8/10

RSI

61.4

Range 1M

80.2%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

24/30

Estimates

1/20

Inst/Vol

3/15

Options

8/10

EPS Yr

78.6%

EPS NY

384.4%

52W%

42.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +63.3% upside

Quality

7/30

Valuation

14/30

Growth

16/25

Stability

7/10

LT Trend

4/5

Upside

+63.3%

Quality

Evolus, Inc. Common Stock

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 350

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

EOLS

Latest News

—

Caricamento notizie per EOLS…

stock quote shares EOLS – Evolus, Inc. Stock Price stock today

news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch EOLS – Evolus, Inc. yahoo finance google finance

stock history EOLS – Evolus, Inc. invest stock market

stock prices EOLS premarket after hours

ticker EOLS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: EOLS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y